Gattex

FDA approves GATTEX for children with short bowel syndrome
Pharmaceutical Business Review
Mon, 05/20/19 - 10:13 am
Takeda
FDA
Gattex
short bowel syndrome
pediatrics
Should Biogen and Shire investors be wary of the latest patent challenges?
Bizjournals.com
Thu, 04/23/15 - 04:56 pm
patents
Biogen
Shire
Thalomid
Gattex
Innovate or Else: Kyle Bass Strikes Again and Challenges Shire Patents
WSJ Pharmalot
Fri, 04/3/15 - 08:36 am
Shire
innovation
patents
Lialda
Gattex
Is NPS Pharmaceuticals The Next Alexion?
Seeking Alpha
Tue, 02/25/14 - 11:03 am
NPS Pharmaceuticals
Alexion
NPSP795
Gattex
NPS, Iroko show how companies can grow sales, not staff
Fierce Pharma
Fri, 02/14/14 - 01:01 pm
NPS Pharmaceuticals
Iroko Pharmaceuticals
Zorvolex
Gattex
NPS Pharma Finds Big Success In Tiny Markets
Investors.com
Fri, 02/14/14 - 12:00 pm
NPS Pharmaceuticals
Gattex
short bowel syndrome
Natpara
hypoparathyroidism
NPS Pharmaceuticals sees FY13 net global Gattex sales approx. $31.5M
Yahoo/Fly on the Wall
Wed, 01/8/14 - 09:27 am
Gattex
NPS Pharmaceuticals
revestive
NPS Pharma Commences Study on Pediatrics
Yahoo/Zacks.com
Fri, 01/3/14 - 11:50 am
pediatrics
NPS Pharmaceuticals
Gattex
short bowel syndrome
4 Healthcare Stock Stories Making Midweek Headlines
Wall St Cheat Sheet
Thu, 11/14/13 - 10:15 am
BAX 855
Baxter International
plecanatide
Synergy Pharmaceuticals
layoffs
Transcept
NPS Pharmaceuticals
Gattex
NPS Pharmaceuticals Has A Billion Plus Blockbuster On Its Hands
Seeking Alpha
Tue, 08/13/13 - 10:55 am
NPS Pharmaceuticals
Gattex
short bowel syndrome
The Profitable Business of Developing Orphan Drugs
Motley Fool
Tue, 06/4/13 - 12:44 pm
orphan drugs
NPS Pharmaceuticals
Gattex
Soliris
Alexion
Genzyme
Renagel
Cerezyme
Fabrazyme
Sanofi
NPS Buys Back Rights to Gattex From Takeda to Spur Sales
Bloomberg
Tue, 03/19/13 - 11:06 am
NPS Pharmaceuticals
Takeda
Gattex
short bowel syndrome
NPS Pharmaceuticals Chief: Why 250k-a-Year Orphan Drug is Worth It
Y Charts
Sun, 02/3/13 - 11:35 am
Gattex
NPS Pharmaceuticals
short bowel syndrome
3 Drug Launches You Need to Know in 2013
Motley Fool
Wed, 01/16/13 - 11:18 am
NPS Pharmaceuticals
Gattex
short bowel syndrome
Iclusig
Ariad
chronic myeloid leukemia
Pfizer
Eliquis
Bristol-Myers Squibb
4 FDA Approvals in 1 Day
Motley Fool
Wed, 12/26/12 - 09:30 am
FDA
drug approvals
Roche
Tamiflu
Gilead Sciences
Gattex
NPS Pharmaceuticals
Alexza
Adasuve
VariZIG
Cangene
NPS Gattex Wins Approval for Short-Bowel Syndrome
Bloomberg
Sat, 12/22/12 - 12:19 pm
Gattex
short bowel syndrome
NPS Pharmaceuticals
3 Things to Watch at NPS Pharmaceuticals
Motley Fool
Thu, 12/6/12 - 10:48 am
NPS Pharmaceuticals
Gattex
Natpara
NPS Pharma Drifts Higher On Potential Orphan Drug Approval
Seeking Alpha
Tue, 12/4/12 - 01:33 pm
NPS Pharmaceuticals
orphan drugs
short bowel syndrome
Gattex
FDA panel votes to support NPS Pharma bowel drug
Yahoo/AP
Wed, 10/17/12 - 11:55 am
NPS Pharmaceuticals
FDA
short bowel syndrome
Gattex
advisory panels
NPS shares halted as FDA panel reviews bowel drug
Yahoo/AP
Tue, 10/16/12 - 11:52 am
NPS Pharmaceuticals
FDA
advisory panels
Gattex
short bowel syndrome

Pages